Putting people at the heart of hybrid work: Zoom to acquire Workvivo to bolster the employee experience offering

The employee communication and engagement platform will give Zoom customers new ways to keep employees informed, engaged, and connected in today’s hybrid work model

Zoom and Workvivo

Zoom announces intent to acquire Workvivo

SAN JOSE, Calif., April 14, 2023 (GLOBE NEWSWIRE) — Behind work are workers. Real everyday people. People who work to live, not live to work. People who need a sense of belonging. It’s a simple concept that often gets forgotten as priorities and demands take over the workday.

With workforces looking much different than they did just a few years ago, leaders need to think differently to retain talent and maintain company culture. Today’s workforce is hybrid and distributed – with people working from home, in an office, at a remote location, on the frontlines of a retail floor or warehouse, as a pilot or flight attendant in an airplane, a nurse in a healthcare clinic, or anything in between. In fact, 70% of US employees are frontline workers. They are people who want to feel connected to their colleagues and leaders – no matter where they work. Engaging employees and driving culture through connection is no longer a ‘nice to have’ – it’s imperative for success in today’s business environment.

Zoom is excited to announce the acquisition of Workvivo to extend Zoom’s platform and offer its customers new ways to keep employees informed, engaged, and connected.

Founded in 2017, Workvivo provides a modern, feature-rich employee experience platform, combining advanced internal communication and engagement tools, a social intranet, and an employee app, all blended into one central hub, forming the heart of a company’s digital ecosystem. Workvivo’s best-in-class offering has seen triple-digit growth in the last three years and is used and trusted by hundreds of customers worldwide, from SMBs to some of the world’s most well-known brands, including Liberty Mutual, Lululemon, Ryanair, Madison Square Garden, and Wynn Resorts.

“We are excited to welcome the Workvivo team to Zoom. The power of Workvivo employee experience platform, with its robust communications and engagement offering combined with Zoom’s all-in-one collaboration platform, allows organizations to fully unlock the potential of their employees and evolve their company culture in a hybrid world,” said Kelly Steckelberg, chief financial officer at Zoom. “Workvivo has set the standard for employee communications, helping businesses reach and engage millions of employees worldwide. Workvivo prioritizes ease-of-use and simplicity of design, offering the best user experience which is a perfect match to Zoom’s DNA.”

“Zoom’s rapid pace of innovation and the persistent dedication to building products with a human-first mindset is why we are most excited about joining the team,” said John Goulding, CEO and co-founder at Workvivo. “Our platform replaces outdated, clunky, internal communications tools with a vibrant, familiar social experience, and has a proven history of unparalleled levels of adoption. With Zoom, we can build great things together, make teamwork more meaningful, and extend collaboration beyond knowledge workers, allowing us to reach employees who have historically felt disconnected from the company.”

Workvivo UI
Workvivo is an employee experience platform designed to inform, engage and connect employees everywhere.

Workvivo is an employee experience platform designed to inform, engage and connect employees everywhere.

With this acquisition, Zoom continues its evolution to provide the best end-to-end collaboration platform focused on enabling modern work and powering the digital-first workplace.

Following the close of the transaction, Zoom plans to incorporate Workvivo’s capabilities into its platform to deliver a best-in-class, employee experience. Workvivo’s founders John Goulding and Joe Lennon, and the entire Workvivo team, will be instrumental in driving employee experience innovation strategy.

The transaction is expected to close in Q1 FY2024. Terms of the transaction were not disclosed.

About Zoom
Zoom is an all-in-one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

About Workvivo
Workvivo is an employee experience platform designed to inform, engage and connect employees everywhere. Workvivo works with organizations globally across multiple industries, including Bupa, TELUS International and Everton FC. Read more at www.workvivo.com.

Forward-Looking Statements
This news release contains forward-looking information related to Zoom and Workvivo and the acquisition of Workvivo by Zoom that involves substantial risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements in this communication include, among other things, statements regarding the potential benefits of the proposed transaction for Zoom, Workvivo and their respective customers, Zoom’s plans, objectives, expectations and intentions with respect to the proposed transaction, Zoom’s ability to offer the best end-to-end collaboration platform, the financial condition, results of operations and business of Zoom, and the anticipated closing of the proposed transaction. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “will,” “would,” “should,” “could,” “can,” “predict,” “potential,” “target,” “explore,” “continue,” or the negative of these terms, and similar expressions intended to identify forward-looking statements. By their nature, these statements are subject to numerous uncertainties and risks, including factors beyond our control, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements, including: risks related to the ability of Zoom to consummate the proposed transaction on a timely basis or at all, Zoom’s ability to successfully integrate Workvivo’s operations and personnel, Zoom’s ability to implement its plan, forecasts and other expectations with respect to Workvivo’s business after the completion of the transaction, the ability to realize the anticipated benefits of the proposed transaction, and continued uncertainty regarding the extent and duration of the impact of COVID-19 and the responses of government and private industry thereto, including the potential effect on Zoom’s user growth rate as the impact of the COVID-19 pandemic tapers. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements described under the caption “Risk Factors” and elsewhere are in Zoom’s most recent filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended January 31, 2023. Forward-looking statements speak only as of the date the statements are made and are based on information available to Zoom at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. Zoom assumes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, except as required by law.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/ed1d522c-0c14-4cdf-9ace-60dedc4803fe

https://www.globenewswire.com/NewsRoom/AttachmentNg/c5bf41ea-2326-4305-a9a5-df5fa9bc89d5

Zoom Public Relations
Candace Dean
press@zoom.us

Solvvy Public Relations
Eleanor O’Mahony
eleanor.omahony@workvivo.com

GlobeNewswire Distribution ID 8808322

Centro Semillero Offers Two Master’s Programs and Endless Possibilities

Houston, Texas, April 13, 2023 (GLOBE NEWSWIRE) — You may have heard the motto, “Those who dare to teach must never cease to learn.” This principle strongly applies to two Houston-area educators who, through Centro Semillero at University of St. Thomas-Houston (UST), have confirmed their callings as teachers and fortified their faith. Moreover, they are applying the academic program’s four pillars — kindness, discipline, knowledge, and community — to everything they do.

Angel de Jesus Garcia, Current Master’s Student

One of them is Angel de Jesus Garcia, a college advisor at Houston Independent School District and currently enrolled in Centro Semillero’s Master of Sacred Scriptures Program.

“When my friends told me that St. Thomas was about to launch a master’s degree program in Spanish, I went to orientation and decided to give it try,” Garcia said. “That’s how I became part of the first generation of Spanish-speaking theology students, and I thank God for that decision.”

Garcia made this decision because it perfectly supported both his profession as an educator and his after-work role as a leader at his parish’s youth ministry where he attends pastoral meetings, plans retreats, and creates Christian formation programs.

About Centro Semillero

Centro Semillero was created in 2019 as a graduate studies program in pastoral and biblical studies theology at the UST School of Humanities. Offered online and 100% in Spanish, Centro Semillero offers two postgraduate programs: a Master’s in Pastoral Theology and a Master’s in Sacred Scriptures.

“Centro Semillero,” according to its director Father Dempsey Rosales Acosta, “is inspired by the book of Proverbs 2:2-3 when fulfilling the invitation to incline our hearts to the understanding and study of God to grow in his love. Our center offers the opportunity to fulfill this goal of personal and professional growth by obtaining a postgraduate degree in pastoral or biblical studies at UST from the comfort of your home with our 100% online programs.”

Iris Lai Nayas, MAPT ‘21

For Iris Lai Nayas, a 9th-grade Spanish teacher at Pasadena Independent School District, and a graduate of the Pastoral Theology program in 2021, the concepts she learned have opened a door for dialogue with colleagues from other religions.

Nayas said, “The program has helped me find pastoral strategies for interacting with my colleagues, who are not necessarily Catholic. The strategies enable me to dialogue with all of my colleagues and live experiences of faith without losing the essence of mine.”

Most importantly, the program has made her realize that through her interactions with her students and peers, she can be a testament to God’s presence.

“Today, schools they have taken God out of the classroom but thanks to this program, I understand that God has never been outside, and it is up to me to present him, through values, justice, love, prudence, prayer, and faith,” adds Nayas.

Thanks to her graduate degree, Nayas is also a facilitator in the Small Communities of Salt and Light of Maryknoll Fathers and Brothers.

How to Enroll

Centro Semillero has open enrollment for new students. To learn more about Centro Semillero click here.

Attachments

Sandra Soliz
University of St. Thomas - Houston
713-906-7912
solizs@stthom.edu

GlobeNewswire Distribution ID 8807777

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Raises $3 Million from its At-the-Market Equity Offering 

Mont-Saint-Guibert, Belgium – April 13, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on December 22, 2022 at an issue price equal to the market price on the Nasdaq Global Market at the time of the sale. The proceeds will be used for general corporate purposes.

The ordinary shares described above were sold pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-268955), previously filed with the Securities and Exchange Commission (“SEC”) on December 22, 2022, which became effective on January 6, 2023, and a prospectus supplement dated January 6, 2023 and the accompanying prospectus the Company filed with the SEC in connection with the offer and sale of the Company’s common stock pursuant to the Controlled Equity OfferingSM Sales Agreement, dated as of December 22, 2022 with Cantor Fitzgerald & Co., as sales agent (prospectus@cantor.com).

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD-LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 22, 2023, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000803834